Evaluation of antiulcer activity of diltiazem in rats
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20175548Keywords:
Diclofenac, Gastric ulcer, Peptic ulcer, RanitidineAbstract
Background: The risk factors for patients with cardiovascular diseases and gastrointestinal diseases overlap. Majority of the patients have both problems coexistent. Thus, there is need of medicine that can be used for both the diseases.
Methods: Rats weighing 150-250gm of either gender were procured for the study from central animal house. The animals were divided into 7 groups. Control group (Distilled water 2ml), diclofenac sodium (12mg/kg), diltiazem (10mg/kg), diltiazem (30mg/kg), diltiazem (60mg/kg), ranitidine (8mg/kg), ranitidine (16mg/kg). After six hours, scarification of animals was done by cervical dislocation. Size of ulcer, number of gastric ulcers, mean gastric irritancy index, ulcer index, and ulcer scoring were the parameters that were studied.
Results: Diltiazem in dose of 10, 30 and 60 mg/kg showed reduction in all parameters in dose dependent manner. Diltiazem (60mg/kg) showed marked reduction in mean diameter of ulcerated surface area (0.46±0.36), number of ulcers (4.10±2.05), size of ulcers (1.07±0.48), total mucosal surface area (7.60±1.38), and total ulcerated surface area (0.263±0.3). Diltiazem (60mg/kg) showed significant reduction of the parameters as compared to other doses of Diltiazem. Also, diltiazem (60mg/kg) was comparable to Ranitidine in all the parameters. Diltiazem (60mg/kg) also showed reduction in average number of ulcers, ulcer index, mean gastric irritancy index and ulcer scoring as compared to diclofenac sodium (12mg/kg).
Conclusions: Diltiazem has shown to have ulcer prevention property; this can be useful in patients having concomitant cardiovascular and gastrointestinal problems.
References
Siddique RA. Prevalence of peptic ulcer disease among the patients with abdominal pain attending the department of medicine in Dhaka medical college hospital, Bangladesh. Bangladesh. 2014;13(1):2279-0861.
Dutta AK, Chacko A, Balekuduru A, Sahu M, Gangadharan SK. Time trends in epidemiology of peptic ulcer disease in India over two decades. Indian J Gastroenterol. 2012:31(3):111-5.
Sharma SK, Maharjan DK, Thapa PB. Hospital based analytic study of peptic ulcer disease in patients with dyspeptic symptoms. Kathmandu University Med J. 2009;7(2):135-8.
Subudhi BB, Sahoo SP, Sahu PK. Updates in Drug Development Strategies against Peptic ulcer. J Gastrointest Dig Syst. 2016;6:398.
Sultana N, Arayne MS, Shafi N. In vitro interaction studies of diltiazem with H2-receptor antagonists. Med Chem Res. 2010;19:698-716.
Santos SR, Storpirtis S, Moreira-Filho L, Donzella H, Kirch W. Ranitidine increases the bioavailability of nitrendipine in patients with arterial hypertension. Braz J Med Biol Res. 1992;25:337–347.
Jain SM, Parmar NS, Santani DD. Gastric Antiulcer Activity of Calcium Channel Blockers in Rats. Indian J Pharmacol. 1994;26:29-34.
Bhave AL, Bhatt JD, Hemavathi KG. Antiulcer effect of amlodipine and its interaction with H2 blocker and proton pump inhibitor in pylorus ligated rats. 2006;38(6):403-7.
Patil AN, Advani MG, Mali SN, Pawar S, Raut SB. Evaluation of anti-ulcer effect of amlodipine in gastric ulcer models in rats. Indian J Pharmacol. 2012;44:387-9.
Sharif Z, Dugani A. Potentiation of the Gastroprotective Effect of Ranitidine by Verapamil in Ethanol Induced Ulcer in Rats. Int J Pharma Bio Arc. 2013;4(4):696-705.
Kadalmani B. Kumar SM, Revathi P, Shyam KP. Gastric Ulcer Protective Property of Calcium Channel Blockers In Male Albino Rats. Int J Pharma Bio Sci. 2011;2(1):632-6.
Kilic FS, Sirmagul B, Batu O, Erol K. Dose dependent effects of Verapamil on Ethanol- Induced Gastric Lesions in Rats. J Health Sci. 2006;52(6):781-6.
Brage R, Cortijo J, Esplugues J, Esplugues JV, Marti B, Rodriguez C. Effects of calcium channel blockers on gastric emptying and acid secretion of the rat in vivo. Br J Pharmac. 1986;89:627-33.
Wong WS, Rahwan RG. Antiulcer activity of the calcium antagonist propyl-methylenedioxyindene I. Effect on cold/restraint stress-induced ulcers in rats. Gen Pharmacol. 1990;21:321-5.
Mandal S, Roy RK, Das HN, Aditya GN, Chattopadhyay RN, Lahiri HL. Potentiation of gastric antiulcer effect of famotidine by calcium channel blockers in rats. Indian J Pharmacol.1998;30:390-3.
